rs757937208
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PP2PP3_ModeratePP5_Very_Strong
The NM_014874.4(MFN2):c.334G>A(p.Val112Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_014874.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- axonal hereditary motor and sensory neuropathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251486 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727236 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; Pathogenic:3
- -
The missense c.334G>Ap.Val112Met variant has been reported in homozygous state in an individuals affected with Charcot-Marie-Tooth disease Kanwal S, et. al., 2021. The p.Val112Met variant has been reported with allele frequency of 0.001% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes database. This variant has been reported to the ClinVar database as Uncertain Significance/Pathogenic/Likely pathogenic. The amino acid change p.Val112Met in MFN2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Val at position 112 is changed to a Met changing protein sequence and it might alter its composition and physico-chemical properties. Additional functional studies are required to prove pathogenicity of the variant. For these reasons, this variant has been classified as Likely pathogenic. -
Recessive condition -
Charcot-Marie-Tooth disease type 2A2 Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.334G>A (p.V112M) alteration is located in exon 5 (coding exon 3) of the MFN2 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the valine (V) at amino acid position 112 to be replaced by a methionine (M). Based on the available evidence, the MFN2 c.334G>A (p.V112M) alteration is pathogenic for autosomal recessive MFN2-related neuropathy; however, its clinical significance for autosomal dominant MFN2-related neuropathy is uncertain. Based on data from gnomAD, the A allele has an overall frequency of 0.002% (4/251486) total alleles studied. The highest observed frequency was 0.01% (3/30616) of South Asian alleles. This alteration was detected in the homozygous state in multiple individuals with MFN2-related neuropathy cosegregates with disease in one family (Taghizadeh, 2020; Kanwal, 2021; Sharma, 2022; Asif, 2023). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Peripheral neuropathy Pathogenic:1
- -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 112 of the MFN2 protein (p.Val112Met). This variant is present in population databases (rs757937208, gnomAD 0.01%). This missense change has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 32657593, 33415332, 34193129). ClinVar contains an entry for this variant (Variation ID: 587402). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MFN2 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at